Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 402
Selected: 0
NCT IDTitle
NCT02880020Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery
NCT00335751PET Scan Combined With CT Scan in Evaluating Treatment Response in Patients Undergoing Treatment for Bone Cancer or Soft Tissue Sarcoma
NCT05775471Pembrolizumab and Enfortumab Vedotin With Pembrolizumab Prior to and After Radical Nephroureterectomy for High-Risk Upper Tract Urothelial Cancer
NCT00882765Genistein in Treating Patients With Pancreatic Cancer That Can Be Removed by Surgery
NCT06090903Magnetic Resonance Imaging for Improving Knowledge of Brain Tumor Biology in Patients With Resectable Glioblastoma
NCT01345136Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma
NCT00005083Functional Magnetic Resonance Imaging and 1H-Nuclear Magnetic Resonance Spectroscopic Imaging in Treating Patients With Newly Diagnosed Brain Tumors
NCT04348682Expanded Access Protocol of 68Ga-PSMA-11 for PET Imaging
NCT00427427Delayed Adjuvant Herceptin® Treatment in Patients With HER-2 Positive Breast Cancer
NCT01180868The Biodistribution of 1-L-(2 Deoxy-2,- 18 Fluoroarabinofuranosyl) Cytosine ([18F]L-FAC) in Healthy Subjects and Patients With Cancer, Autoimmune and Inflammatory Diseases
NCT00020878Celecoxib in Preventing Non-Small Cell Lung Cancer in Tobacco Smokers
NCT01029925Dichloroacetate (DCA) in Patients With Previously Treated Metastatic Breast or Non-Small Cell Lung Cancer (NSCL)
NCT00104767Celecoxib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT03409419PET Imaging of the Immune System Using Analog Probes
NCT02310594Anti-tumor Immune Response in Patients With Cancer Undergoing Radiation Therapy
NCT00112983Eculizumab in Treating Patients With Paroxysmal Nocturnal Hemoglobinuria
NCT00509431Erlotinib and Sirolimus in Treating Patients With Recurrent Malignant Glioma
NCT02925351Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases
NCT00004881Vaccine Therapy in Treating Patients With Advanced Cancer
NCT00335868PHA-739358 in Treating Patients With Chronic Myelogenous Leukemia That Relapsed After Imatinib Mesylate or c-ABL Therapy
NCT00253617Stent Placement With or Without Photodynamic Therapy Using Porfimer Sodium as Palliative Treatment in Treating Patients With Stage III or Stage IV Cholangiocarcinoma That Cannot Be Removed By Surgery
NCT00090909Gemcitabine, Cisplatin, and Dexamethasone in Treating Patients With Relapsed or Refractory Hodgkin's Lymphoma
NCT04069923OsteoCrete in Filling Bone Voids in Participants With Bone Voids or Defects
NCT02701023Compassionate Use of MitoGel in Upper Tract Urothelial Carcinoma
NCT04299620Micro-Ultrasound for the Detection and Localization of Prostate Cancer Tumors in Patients Undergoing Radical Prostatectomy
NCT00070382Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
NCT00006968Pentostatin Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Kidney Cancer
NCT04069910Stereotactic Radiation Therapy Before Surgery for the Treatment of Resectable Brain Metastases
NCT03319342Kindness Interventions in Enhancing Well-Being in Breast Cancer Survivors
NCT02048020Paclitaxel and Carboplatin Before Radiation Therapy With Paclitaxel in Treating HPV-Positive Patients With Stage III-IV Oropharynx, Hypopharynx, or Larynx Cancer
NCT04147494Experimental PET Imaging Scans Before Cancer Surgery to Study the Amount of PET Tracer Accumulated in Normal and Cancer Tissues
NCT02224911Use of Laser Interstitial Thermal Therapy in the Focal Treatment of Localized Prostate Cancer
NCT00081068Alemtuzumab in Treating Patients With Waldenstrom's Macroglobulinemia
NCT03892720Stereotactic Body Radiation Therapy Using HyperArc in Treating Patients With Recurrent Head and Neck Cancer
NCT00068510Vaccine Therapy in Treating Patients With Malignant Glioma
NCT06934239A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
NCT00004878Donor Lymphocytes to Prevent Graft-Versus-Host Disease in Patients With Chronic Myeloid Leukemia
NCT00087035Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer
NCT00093730BMS-599626 in Treating Patients With Metastatic Solid Tumors
NCT00072072Celecoxib and Erlotinib in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
NCT07229339Zipalertinib With Carboplatin and Pemetrexed for the Treatment of Resectable, Stage II-IIIB, Non-Small Cell Lung Cancer
NCT07077239Prostate Cancer Postoperative Stereotactic Body Radiotherapy With Adaptive Technology for Minimizing Toxicity
NCT00093587Antithymocyte Globulin and Cyclosporine in Preventing Graft-Versus-Host Disease in Patients Undergoing Chemotherapy With or Without Radiation Therapy Followed By Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia
NCT05595499Fisetin to Improve Physical Function in Stage I-III Breast Cancer Survivors
NCT03014804Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen Vaccine and Nivolumab in Treating Patients With Recurrent Glioblastoma
NCT04945642High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
NCT00087061Gimatecan in Treating Patients With Recurrent or Progressive Primary Malignant Glioma
NCT04703101Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
NCT00090857Letrozole in Preventing Breast Cancer in Postmenopausal Women
NCT00112775BMS-354825 or Imatinib Mesylate in Treating Patients With Chronic Phase Chronic Myelogenous Leukemia That Did Not Respond to Previous Imatinib Mesylate